LYTIR

Insider · SEC Form 4 · Chief Executive Officer

Ceesay Abraham

In the 12 months to Nov 8, 2026, on the open market: sold $4.8M of RAPP. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $4.8M in total.Jun: Insider sales $327KJul: Insider sales $421KAug: Insider sales $3.4MSep: Insider sales $461KOct: Insider sales $208KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $4.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. RAPPSold: Rapport Therapeutics, Inc. Oct 21, 2026 2,210 shares filed Oct 23, 2026 450,035 shares held directly after, as filed 10b5-1 plan filing $64K
  2. RAPPSold: Rapport Therapeutics, Inc. Oct 7, 2026 1,147 shares filed Oct 8, 2026 452,245 shares held directly after, as filed 10b5-1 plan filing $35K
  3. RAPPSold: Rapport Therapeutics, Inc. Oct 6, 2026 3,375 shares filed Oct 8, 2026 453,392 shares held directly after, as filed 10b5-1 plan filing $108K
  4. RAPPSold: Rapport Therapeutics, Inc. Sep 23, 2026 2,210 shares filed Sep 24, 2026 3 transactions 10b5-1 plan filing $87K
  5. RAPPSold: Rapport Therapeutics, Inc. Sep 8, 2026 8,210 shares filed Sep 9, 2026 2 transactions 10b5-1 plan filing $374K
  6. RAPPSold: Rapport Therapeutics, Inc. Aug 25, 2026 18,921 shares filed Aug 26, 2026 467,187 shares held directly after, as filed 10b5-1 plan filing $938K
  7. RAPPSold: Rapport Therapeutics, Inc. Aug 11, 2026 28,958 shares filed Aug 12, 2026 3 transactions 10b5-1 plan filing $1.4M
  8. RAPPSold: Rapport Therapeutics, Inc. Aug 10, 2026 22,541 shares filed Aug 12, 2026 2 transactions 10b5-1 plan filing $1.0M
  9. RAPPSold: Rapport Therapeutics, Inc. Jul 27, 2026 2,210 shares filed Jul 29, 2026 2 transactions 10b5-1 plan filing $93K
  10. RAPPSold: Rapport Therapeutics, Inc. Jul 14, 2026 8,210 shares filed Jul 15, 2026 2 transactions 10b5-1 plan filing $328K
  11. RAPPSold: Rapport Therapeutics, Inc. Jun 29, 2026 8,220 shares filed Jul 1, 2026 2 transactions 10b5-1 plan filing $327K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.